financetom
Business
financetom
/
Business
/
Ripple applies for US national bank charter as crypto eyes next frontier
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ripple applies for US national bank charter as crypto eyes next frontier
Jul 2, 2025 11:13 AM

July 2 (Reuters) - Crypto firm Ripple is applying for a

national bank charter in the U.S., its CEO Brad Garlinghouse

wrote in a social media post on Wednesday, shortly after a

similar step by stablecoin giant Circle.

The move reflects a broader push by crypto firms for

regulatory clarity and deeper integration with the traditional

financial system.

A charter would allow crypto companies to settle payments

faster and cut costs by bypassing intermediary banks, while also

providing a stamp of legitimacy after years of what they claim

has been regulatory sidelining.

Ripple's charter will need to be approved by the Office of

the Comptroller of the Currency, a top banking regulator.

The OCC did not immediately respond to a Reuters request for

comment.

The company is also seeking a Fed Master account that would

give it access to the Federal Reserve's payments infrastructure

and allow it to hold its stablecoin reserves directly with the

central bank, Garlinghouse wrote on X.

Ripple launched its stablecoin, RLUSD, in October last year.

While much smaller than dominant players Tether and Circle's USD

Coin, RLUSD still ranks among the biggest stablecoins by market

value, according to data from CoinMarketCap.

Ripple, founded in 2012, operates a blockchain that

facilitates crypto payments. Besides its stablecoin, it also

runs the XRP cryptocurrency.

Earlier this week, stablecoin firm Circle also said it is

applying to create a national trust bank in the U.S., weeks

after its robust initial public offering.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved